Type : | Académique |
Statut : | Ouvert |
Phase : | IV |
Étape du traitement : | Traitements combinés |
Date d'ouverture : | 15/04/2022 |
Date clôture : | 01/08/2025 |
Promoteur : | Centre Georges Francois Leclerc |
Progression du cancer: | Loco-régional |
Résumé :
Patients including of localized breast cancer will require chemotherapy treatment with epirubicin - cyclophosphamide (EC) followed by treatment with docetaxel or paclitaxel. In addition to this chemotherapy, the investigator will prescribe injections of granulocyte growth factors (G-CSF), to stimulate the growth of white blood cells. Patients will be randomized to either a peg-G-CSF arm or a G-CSF arm, prescribed at different times.
The aim is to determine whether one of the two treatment regimens best limits the risk of a decrease in white blood cells
Domaines/spécialités :
- Cancer du sein
Pathologies :
- Tumeur maligne du sein - Cim10 : C50
Liens externes :